Social Media Influencers Driving Parallel Market for Unlicensed Slimming Medication

An underground market for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Treatment Gaining Popularity Online

The experimental drug, which remains in research studies, is being promoted by online personalities for its alleged weight-reducing properties. Followers are encouraged to message these accounts privately for source information, while also obtaining discount codes.

Active Commerce on Social Networks

Additionally, a robust market exists on messaging services, where communities with thousands of participants share “before and after” images, injection guides and assertions of next-day British shipping. Sellers promote the drug there before redirecting buyers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Professionals Voice Concerns

However, physicians and pharmacists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to users administering substances of uncertain source.

Several experts stated the popularity for the experimental drug could be linked to the rising price of approved slimming treatments such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for human use under the British medical regulations.

Several influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach medicines, marketing, and customer regulations, potentially leading to penalties, prosecution or imprisonment.

Platform Reaction and Material Removal

Based on the social media company, the platform has taken down problematic material and banned related hashtags and query recommendations. The company said it was dedicated to maintaining the platform secure and investing in strengthening compliance measures.

Digital Marketplace Activities

Investigations also discovered communities with up to nine thousand members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with numerous of users, filled with images of slimming results, positive reviews and detailed guides for preparing or injecting at residence.

After minutes of joining one community, a seller shared contact information, where most transactions occur. The vendor sent an instruction manual and promised shipping within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about weight, medical conditions or previous experience.

Item Information and Pricing

Within these groups, messages show dark colored parcels with Royal Mail stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When questioned how much time a injector should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for the messaging service stated it regularly monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they can’t verify. Even if the research behind retatrutide is valid, these online products may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she explained.

Her staff has already seen patients harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly said the substance was in third stage research studies and had not been reviewed or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company experimental product not yet authorized … may subject patients to possibly significant health risks”.

Timothy Alexander
Timothy Alexander

A passionate gamer and tech enthusiast with over a decade of experience in game journalism and community building.